Sartorius Stedim Biotech SA SDMHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SDMHF is a good fit for your portfolio.
News
-
Sartorius Stedim Biotech Shares Fall After Capital Increase
-
Sartorius Stedim Biotech Completes $1.3 Billion Capital Increase
-
Sartorius's Shares Drop on Outlook Cut, Preliminary 3Q Declines
-
Sartorius, Sartorius Stedim shares fall after Polyplus acquisition
-
Sartorius, Sartorius Stedim Shares Fall After Polyplus Acquisition
-
Sartorius Inks $2.6 Billion Deal for French Gene-Therapy Tech Firm Polyplus
Trading Information
- Previous Close Price
- $224.29
- Day Range
- $224.44–224.82
- 52-Week Range
- $175.12–321.11
- Bid/Ask
- $217.18 / $222.96
- Market Cap
- $21.84 Bil
- Volume/Avg
- 225 / 181
Key Statistics
- Price/Earnings (Normalized)
- 46.06
- Price/Sales
- 6.57
- Dividend Yield (Trailing)
- 0.33%
- Dividend Yield (Forward)
- 0.36%
- Total Yield
- 0.33%
Company Profile
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 10,493
- Website
- https://www.sartorius.com
Competitors
Valuation
|
Metric
|
SDMHF
|
MRK
|
TMO
|
|---|---|---|---|
Price/Earnings (Normalized) | 46.06 | 19.26 | 26.68 |
Price/Book Value | 6.76 | 2.41 | 4.75 |
Price/Sales | 6.57 | 3.06 | 5.20 |
Price/Cash Flow | 41.52 | 14.30 | 25.05 |
Price/Earnings
SDMHF
MRK
TMO
Financial Strength
|
Metric
|
SDMHF
|
MRK
|
TMO
|
|---|---|---|---|
Quick Ratio | 0.49 | 0.79 | 1.27 |
Current Ratio | 1.51 | 1.42 | 1.75 |
Interest Coverage | 4.38 | 11.32 | 4.94 |
Quick Ratio
SDMHF
MRK
TMO
Profitability
|
Metric
|
SDMHF
|
MRK
|
TMO
|
|---|---|---|---|
Return on Assets (Normalized) | 6.21% | 7.55% | 8.68% |
Return on Equity (Normalized) | 15.23% | 13.81% | 18.83% |
Return on Invested Capital (Normalized) | 9.77% | 10.19% | 11.14% |
Return on Assets
SDMHF
MRK
TMO
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Kznwdlykt | Rtg | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Kdtblpjjl | Pvxkww | $67.6 Bil | |
ALC
| Alcon Inc | Pvkdrhtb | Vdjrc | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Xjjzvylsn | Nkg | $29.7 Bil | |
WST
| West Pharmaceutical Services Inc | Xlrksnmwy | Wbbx | $28.6 Bil | |
RMD
| ResMed Inc | Gytqqpbwt | Hdthyy | $27.0 Bil | |
BAX
| Baxter International Inc | Ctglthtml | Kfxcnm | $20.9 Bil | |
COO
| The Cooper Companies Inc | Dmlcxkhcq | Kccckt | $18.2 Bil | |
HOLX
| Hologic Inc | Hntmsqb | Mjlnzf | $17.9 Bil | |
TFX
| Teleflex Inc | Ckwy | Glpf | $9.9 Bil |